hemotune AG appoints a new Chief Business Officer

At the interface of MedTech and Pharma, hemotune AG is engineering a world‑leading magnetic nanoparticle platform to transform separation across the medical value chain – and beyond.

📢 Today, we are delighted to announce that Christian Brühlmann has joined hemotune as Chief Business Officer. With this appointment, our C‑level expands to three leaders, purpose‑built for scale and sharper client focus. Christian brings more than a decade of experience building and scaling health-tech companies as an entrepreneur, spanning business development, fundraising, finance, and M&A — from early stage to successful exit.

Why now?
From life-saving therapies to advanced biomanufacturing, our magnetic platform transforms purification across the medical value chain. With multiple applications, disciplined scaling matters as much as scientific excellence. A three‑person C‑suite gives us the structural resilience to execute, translating breakthrough purification science into patient benefit and sustainable value, while keeping our clients and partners at the center of every decision.

🤝 Welcome Christian Brühlmann!
We look forward to engaging investors and partners who share our commitment to impact, integrity, and collaboration.